Overview of Dr. Caskey
Dr. Marina Caskey is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. She received her medical degree from Other and has been in practice 19 years. She is one of 140 doctors at New York-Presbyterian Hospital and one of 140 doctors at New York-Presbyterian Hospital who specialize in Infectious Disease. She has more than 70 publications and over 500 citings.
Office
1315 York Avenue
Mezzanine
New York, NY 10021- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2003 - 2006
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2000 - 2003
OtherClass of 1998
Certifications & Licensure
NY State Medical License 2003 - 2025
Clinical Trials
- Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers Start of enrollment: 2009 Nov 01
- Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers Start of enrollment: 2011 Jun 01
- A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- High volume subcutaneous delivery of long-acting HIV bNAbs.Marina Caskey> ;The Lancet. HIV. 2023 Apr 1
- 34 citationsAntibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.Dennis Schaefer-Babajew, Zijun Wang, Frauke Muecksch, Alice Cho, Maximilian Loewe, Melissa Cipolla, Raphael Raspe, Brianna Johnson, Marie Canis, Justin DaSilva, Victor...> ;Nature. 2023 Jan 1
- 3 citationsMonoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?Marina Caskey, Daniel R Kuritzkes> ;Clinical Infectious Diseases. 2022 Nov 21
- Join now to see all
Journal Articles
- Relationship Between Intact HIV-1 Proviruses in Circulating CD4+ T Cells and Rebound Viruses Emerging During Treatment InterruptionMichel C Nussenzweig, Thiago Y Oliveira, Marina Caskey, Proceedings of the National Academy of Sciences
- Safety and Antiviral Activity of Combination HIV-1 Broadly Neutralizing Antibodies in Viremic IndividualsRoy M Gulick, Thiago Y Oliveira, Marina Caskey, Michel C Nussenzweig, Michael S Seaman, Katrina Millard, Nature
- Combination Therapy with Anti-HIV-1 Antibodies Maintains Viral SuppressionMichael S Seaman, Katrina Millard, Marina Caskey, Michel C Nussenzweig, Roy M Gulick, Thiago Y Oliveira, Nature
Press Mentions
How Close Are We to a Cure for HIV?July 6th, 2019
New Therapy May Control HIV Without Daily PillsOctober 26th, 2018
HIV Cure May Lie in Novel Immunotherapy TreatmentSeptember 28th, 2018- Join now to see all
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York- New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
